-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cenobamate in Simple Partial Seizure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cenobamate in Simple Partial Seizure report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cenobamate in Simple Partial Seizure Drug Details: Cenobamate (Xcopri /...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cenobamate in Complex Partial Seizure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cenobamate in Complex Partial Seizure report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cenobamate in Complex Partial Seizure Drug Details: Cenobamate (Xcopri /...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Cenobamate in Tonic-Clonic (Grand Mal) Seizure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cenobamate in Tonic-Clonic (Grand Mal) Seizure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cenobamate in Tonic-Clonic (Grand Mal) Seizure Drug Details: Cenobamate (Xcopri...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Fenfluramine Hydrochloride in Myoclonic Seizure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fenfluramine Hydrochloride in Myoclonic Seizure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fenfluramine Hydrochloride in Myoclonic Seizure Drug Details: Fenfluramine hydrochloride (Fintepla) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Fenfluramine Hydrochloride in Tonic-Clonic (Grand Mal) Seizure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Fenfluramine Hydrochloride in Tonic-Clonic (Grand Mal) Seizure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fenfluramine Hydrochloride in Tonic-Clonic (Grand Mal) Seizure Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XEN-1101 in Tonic-Clonic (Grand Mal) Seizure
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. XEN-1101 in Tonic-Clonic (Grand Mal) Seizure Drug Details: XEN-1101 (1OP-2198) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Perampanel in Amyotrophic Lateral Sclerosis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Perampanel in Amyotrophic Lateral Sclerosis Drug Details: Perampanel (Fycompa) belongs to the class of antiepileptic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cenobamate in Liver Failure (Hepatic Insufficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cenobamate in Liver Failure (Hepatic Insufficiency) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Cenobamate in Liver Failure (Hepatic Insufficiency)Drug Details:Cenobamate (Xcopri/ Ontozry) is an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Befiradol in Drug-Induced Dyskinesia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Befiradol in Drug-Induced Dyskinesia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Befiradol in Drug-Induced DyskinesiaDrug Details:Befiradol (NLX-112, F-13640) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MRNA-1012 in Influenzavirus B Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MRNA-1012 in Influenzavirus B Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.MRNA-1012 in Influenzavirus B InfectionsDrug Details: mRNA-1012 is under development for the...